comparemela.com

Page 8 - Nephrology Dialysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

mRNA COVID-19 Vaccines and Their Risk to Induce a Relapse of : Journal of the American Society of Nephrology

mRNA COVID-19 Vaccines and Their Risk to Induce a Relapse of : Journal of the American Society of Nephrology
lww.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lww.com Daily Mail and Mail on Sunday newspapers.

United kingdomVifor pharmaWalden biosciencesVictoria bardsley department of pathologyEuropean renal associationImmunonephrology working group young nephrologist platformBritish columbia canadianVictoria bardsleyNephrology dialysisCatalyst biosciencesDeutsche forschungsgemeinschaft

Trimethoprim-Sulfamethoxazole vs Amoxicillin Ups Hyperkalemia Risk

Investigators examined hyperkalemia risk with use of the antibiotic trimethoprim-sulfamethoxazole in chronic kidney disease.

Johns hopkins universityUnited statesY joseph hwangJohns hopkins university school of medicineJohns hopkins university schoolNephrology dialysis

New Nordic Renal Diet May Benefit Patients With Moderate CKD

The new Nordic renal diet, a Nordic version of a Mediterranean diet, may provide health benefits to patients with moderate CKD.

Nikita misella hansenUniversity hospital of copenhagenLouise salomoUniversity hospitalNephrology dialysis

Incremental Hemodialysis Confers No Higher Death Risk

Investigators performed a review and meta-analysis to evaluate whether death risk differs between incremental vs conventional hemodialysis.

United kingdomEmma catonUniversity of hertfordshireNephrology dialysis

Health Literacy Linked With CKD Progression, Cardiovascular Events

Adults with CKD and limited health literacy may be burdened with a higher risk of adverse outcomes, such as progression.

United statesMayral estrellaChronic renal insufficiency cohortShort testFunctional health literacyTexas health science centerNephrology dialysis

vimarsana © 2020. All Rights Reserved.